Role of bronchoalveolar lavage in the diagnosis of acute exacerbations of idiopathic pulmonary fibrosis: A retrospective study

BMC Pulmonary Medicine

Volumn 15, Issue 1, 2015, Pages

  Petrosyan, Frunze ^a   Culver, Daniel A ^b   Reddy, Anita J ^b  

^a Johnston Health University of North Carolina Health System Hospital Medicine Department   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute respiratory failure; Bronchoalveolar lavage; Idiopathic pulmonary fibrosis; Interstitial lung disease

Indexed keywords

ANTIBIOTIC AGENT; PREDNISONE;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; BLOOD CULTURE; BRONCHOSCOPY; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL EXAMINATION; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FEMALE; FEVER; FIBROSING ALVEOLITIS; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; LEUKOCYTOSIS; LUNG INFECTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MULTIVARIATE ANALYSIS; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SPUTUM CULTURE; STAPHYLOCOCCUS HOMINIS; STENOTROPHOMONAS MALTOPHILIA; TACHYCARDIA; THORAX RADIOGRAPHY; UNIVARIATE ANALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; ACUTE DISEASE; FOLLOW UP; IDIOPATHIC PULMONARY FIBROSIS; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY;

ACUTE DISEASE; ADULT; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; FOLLOW-UP STUDIES; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84936768720     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-015-0066-3     Document Type: Article

References (23)

1. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King Jr TE, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176(7):636-43.
2. Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, et al. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(12):1698-702.
3. Simon-Blancal V, Freynet O, Nunes H, Bouvry D, Naggara N, Brillet PY, et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration. 2012;83(1):28-35.
4. Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, et al. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology. 2010;15(6):909-17.
5. Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci. 2013;10(7):903-7.
6. Johannson K, Collard HR. Acute exacerbation of idiopathic pulmonary fibrosis: a proposal. Curr Respir Care Rep. 2013;2:4.
7. Kondoh Y, Taniguchi H, Katsuta T, Kataoka K, Kimura T, Nishiyama O, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(2):103-10.
8. Judge EP, Fabre A, Adamali HI, Egan JJ. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Eur Respir J. 2012;40(1):93-100.
9. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004-14.
10. Pesci A, Ricchiuti E, Ruggiero R, De Micheli A. Bronchoalveolar lavage in idiopathic pulmonary fibrosis: what does it tell us? Respir Med. 2010;104 Suppl 1:S70-3.
11. Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Acute exacerbations of interstitial lung diseases. Curr Opin Pulm Med. 2010;16(5):480-6.
12. Wuyts WA, Thomeer M, Dupont LJ, Verleden GM. An algorithm to tackle acute exacerbations in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;177(12):1397. author reply 1398.
13. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
14. Lee JS, Song JW, Wolters PJ, Elicker BM, King Jr TE, Kim DS, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J. 2012;39(2):352-8.
15. Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1(5):369-76.
16. Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37(2):356-63.
17. Schupp JC, Binder H, Jager B, Cillis G, Zissel G, Muller-Quernheim J, et al. Macrophage activation in acute exacerbation of idiopathic pulmonary fibrosis. PLoS One. 2015;10(1):e0116775.
18. Kurosu K, Takiguchi Y, Okada O, Yumoto N, Sakao S, Tada Y, et al. Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis. J Immunol. 2008;181(1):756-67.
19. Sakamoto K, Taniguchi H, Kondoh Y, Wakai K, Kimura T, Kataoka K, et al. Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures. Respir Med. 2012;106(3):436-42.
20. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006;27(1):143-50.
21. Suga T, Sugiyama Y, Ohno S, Kitamura S. Two cases of IIP which developed acute exacerbation after bronchoalveolar lavage. Nihon Kyobu Shikkan Gakkai Zasshi. 1994;32(2):174-8.
22. Hiwatari N, Shimura S, Takishima T, Shirato K. Bronchoalveolar lavage as a possible cause of acute exacerbation in idiopathic pulmonary fibrosis patients. Tohoku J Exp Med. 1994;174(4):379-86.
23. Wells AU. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease. Eur Respir Rev. 2010;19(117):237-41.